User profiles for F. Zampieri
 | Fernando G ZampieriHCor-Hospital do Coração Verified email at hcor.com.br Cited by 9325 |
Balanced crystalloids versus saline in critically ill adults—a systematic review with meta-analysis
Background The comparative efficacy and safety of balanced crystalloid solutions and saline
for fluid therapy in critically ill adults remain uncertain. Methods We systematically reviewed …
for fluid therapy in critically ill adults remain uncertain. Methods We systematically reviewed …
[HTML][HTML] The critical care management of spontaneous intracranial hemorrhage: a contemporary review
Spontaneous intracerebral hemorrhage (ICH), defined as nontraumatic bleeding into the
brain parenchyma, is the second most common subtype of stroke, with 5.3 million cases and …
brain parenchyma, is the second most common subtype of stroke, with 5.3 million cases and …
Current practice and evolving concepts in septic shock resuscitation
…, A Vieillard Baron, JL Vincent, FG Zampieri… - Intensive care …, 2022 - Springer
Clinical and pathophysiological understanding of septic shock has progressed
exponentially in the previous decades, translating into a steady decrease in septic shock-related …
exponentially in the previous decades, translating into a steady decrease in septic shock-related …
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX …
…, T Lisboa, L Kawano-Dourado, FG Zampieri… - Jama, 2020 - jamanetwork.com
Importance Acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19)
is associated with substantial mortality and use of health care resources. …
is associated with substantial mortality and use of health care resources. …
[HTML][HTML] Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Background Hydroxychloroquine and azithromycin have been used to treat patients with
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Objective To determine whether tocilizumab improves clinical outcomes for patients with
severe or critical coronavirus disease 2019 (covid-19). Design Randomised, open label trial. …
severe or critical coronavirus disease 2019 (covid-19). Design Randomised, open label trial. …
[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
…, M Velinova, HL Wong, R Wrenn, FG Zampieri… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial
Importance Intravenous fluids are used for almost all intensive care unit (ICU) patients.
Clinical and laboratory studies have questioned whether specific fluid types result in improved …
Clinical and laboratory studies have questioned whether specific fluid types result in improved …
[HTML][HTML] ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
…, J Villar, LB Ware, B Weiss, FG Zampieri… - Intensive care …, 2023 - Springer
The aim of these guidelines is to update the 2017 clinical practice guideline (CPG) of the
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to adult …
European Society of Intensive Care Medicine (ESICM). The scope of this CPG is limited to adult …
[HTML][HTML] Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil …
…, TD Corrêa, LR Ferraz, MG Lapa, FG Zampieri… - The Lancet, 2020 - thelancet.com
Background The efficacy and safety of azithromycin in the treatment of COVID-19 remain
uncertain. We assessed whether adding azithromycin to standard of care, which included …
uncertain. We assessed whether adding azithromycin to standard of care, which included …